Switch theme
Sign up to access all valuation multiples
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
2010
54
LTM Revenue $37.5M
LTM EBITDA $4.6M
$33.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sensus Healthcare has a last 12-month revenue (LTM) of $37.5M and a last 12-month EBITDA of $4.6M.
In the most recent fiscal year, Sensus Healthcare achieved revenue of $41.8M and an EBITDA of $8.5M.
Sensus Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sensus Healthcare valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $37.5M | XXX | $41.8M | XXX | XXX | XXX |
| Gross Profit | $20.8M | XXX | $24.4M | XXX | XXX | XXX |
| Gross Margin | 55% | XXX | 58% | XXX | XXX | XXX |
| EBITDA | $4.6M | XXX | $8.5M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 20% | XXX | XXX | XXX |
| EBIT | $0.5M | XXX | $8.1M | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $0.8M | XXX | $6.6M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 16% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 15, 2025, Sensus Healthcare's stock price is $3.
Sensus Healthcare has current market cap of $55.1M, and EV of $33.5M.
See Sensus Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $33.5M | $55.1M | XXX | XXX | XXX | XXX | $-0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 15, 2025, Sensus Healthcare has market cap of $55.1M and EV of $33.5M.
Sensus Healthcare's trades at 0.8x EV/Revenue multiple, and 3.9x EV/EBITDA.
Equity research analysts estimate Sensus Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sensus Healthcare has a P/E ratio of 67.5x.
See valuation multiples for Sensus Healthcare and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $55.1M | XXX | $55.1M | XXX | XXX | XXX |
| EV (current) | $33.5M | XXX | $33.5M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 7.3x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBIT | 63.4x | XXX | 4.1x | XXX | XXX | XXX |
| EV/Gross Profit | 1.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 67.5x | XXX | 8.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -30.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSensus Healthcare's last 12 month revenue growth is 14%
Sensus Healthcare's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.3M for the same period.
Sensus Healthcare's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sensus Healthcare's rule of X is 48% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Sensus Healthcare and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | 420% | XXX | XXX | XXX |
| Rule of 40 | 15% | XXX | 35% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 48% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 39% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sensus Healthcare acquired XXX companies to date.
Last acquisition by Sensus Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Sensus Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Sensus Healthcare founded? | Sensus Healthcare was founded in 2010. |
| Where is Sensus Healthcare headquartered? | Sensus Healthcare is headquartered in United States of America. |
| How many employees does Sensus Healthcare have? | As of today, Sensus Healthcare has 54 employees. |
| Who is the CEO of Sensus Healthcare? | Sensus Healthcare's CEO is Mr. Joseph Sardano. |
| Is Sensus Healthcare publicy listed? | Yes, Sensus Healthcare is a public company listed on NAS. |
| What is the stock symbol of Sensus Healthcare? | Sensus Healthcare trades under SRTS ticker. |
| When did Sensus Healthcare go public? | Sensus Healthcare went public in 2016. |
| Who are competitors of Sensus Healthcare? | Similar companies to Sensus Healthcare include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Sensus Healthcare? | Sensus Healthcare's current market cap is $55.1M |
| What is the current revenue of Sensus Healthcare? | Sensus Healthcare's last 12 months revenue is $37.5M. |
| What is the current revenue growth of Sensus Healthcare? | Sensus Healthcare revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Sensus Healthcare? | Current revenue multiple of Sensus Healthcare is 0.9x. |
| Is Sensus Healthcare profitable? | Yes, Sensus Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sensus Healthcare? | Sensus Healthcare's last 12 months EBITDA is $4.6M. |
| What is Sensus Healthcare's EBITDA margin? | Sensus Healthcare's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Sensus Healthcare? | Current EBITDA multiple of Sensus Healthcare is 7.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
